Three times a year the EHDN newsletter appears. Now you can read the summer edition; with latest news from the […]
Three times a year the EHDN newsletter appears. Now you can read the Spring edition – with latest news from […]
24th of April marked the opening of the 12th CHDI conference in Malta. 27th marked the end. What have we learned? HDBuzz has […]
A scientific paper declared a while ago positive results for a trial of the drug deutetrabenazine in Huntington’s disease. The […]
Exciting news for the Huntington’s disease (HD) community! The USA drug regulator, the FDA, has approved a new drug in […]
February 28 was the Rare Disease Day – the day of international recognition for the myriad of little known but […]
Georg Bernhard Landwehrmeyer is a professor of neurology (clinical neurobiology) at Ulm University in the department of neurology where the central [...]
Continue Reading
In the Enroll-HD Newsletter of Autumn 2016 you can read current updates from the global Enroll-HD community. You will find […]
9 October 2016
Review Finds Psychiatric and Behavioral Problems in Huntington’s are often Ignored in Research
A recent review summarizes the scientific literature on behavioral and psychiatric symptoms of Huntington’s disease, noting that plenty of research […]
9 October 2016
The PRIDE-HD trial did NOT show that Pridopidine slows the progression of Huntington’s disease
A recent press release from Teva Pharmaceuticals has the HD community excited, claiming “Pridopidine Demonstrates Slowing of Progression of Huntington […]
Our Funding Partners
